The pages of this web site article contain an in depth discussion of a new and highly effective neurotransmitter approach to treating ADHD medical patients in clinics without
ADHD drugs or drug side effects developed by NeuroResearch Clinics. While on the surface this approach may appear similar to treatment attempted by others in the past, it is differentiated from other approaches by the high degree of effectiveness achieved and the unique way the individual components are used. This approach was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics no-drug approach in treatment, we can help. ADHD drugs In the world of ADHD drugs used for treatment of attention deficit (ADD ADHD) there are two groups of drugs prescribed by doctors: Amphetamines Reuptake Inhibitors
Amphetamines have multiple chemical properties, they are reuptake inhibitors and they are neurotoxins (cause permanent brain damage). Of concern with prescription drugs is: Amphetamines are neurotoxic. (Adderall, Vyvanse) Reuptake inhibitors deplete neurotransmitters (Concerta, Ritalin, Strattera, Focalin) Drug side effects (see drugs linked below)
ADHD drugs Reuptake inhibitors include Concerta, Ritalin, Strattera and Focalin. These drugs under normal conditions deplete neurotransmitters. The reuptake inhibitor ADHD drugs group share the problem that they quit working during treatment at some point in time. The reason for this is drugs that work with neurotransmitters do not work if there is not enough neurotransmitters to work with. When the ADHD drugs quits working it is because the neurotransmitter levels have just depleted by the drug below what levels needed to keep the drug working. When one of these drugs quit working the standard approach in medicine is to: increase the drug dosing add a second drug start a new drug
Each of the treatment options above only serve to deplete neurotransmitter levels in the brain further making the cause of the problem worse. These drugs make the cause of the problem worse, "low neurotransmitter levels". With severe depletion of neurotransmitters the risk of suicide develops. All reuptake inhibitors used to treat depression and attention deficit (ADD ADHD) carry a suicide warning in their prescribing information. For an in depth discussion of how reuptake inhibitors deplete neurotransmitters and induce suicide risk see the links below. Amphetamines ADHD drugs known as Adderall and Vyvanse are amphetamines. All amphetamines are "neurotoxins"' known to cause permanent brain damage. So what does brain damage from an amphetamine look like? In the upper left column of this web page is a link titled "The Diseases". Click on it and it will take you to a list of neurotransmitter diseases. These are the diseases that can develop on a chronic basis with amphetamine use. These diseases usually do not develop while the amphetamine is being taken instead they develop 3 to 5 years after amphetamine ingestion stops. The NeuroResearch Approach Unlike ADHD drugs used in treatment the approach of NeuroResearch Clinics uses nutrients that build neurotransmitters to levels needed for relief of symptoms. The use of nutrients with neurotransmitter testing is a powerful tool and a unique option to ADHD drugs. The Peer Reviewed Research of NeuroResearch Clinics The research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression. | 
